CoChat

Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart

Open access
Blom, Cindy M A, Gómez-Vázquez, Emilio, van Sluis, Marjolein, Marteijn, Jurgen A · 2026 · Nucleic Acids Research

The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index; none of the 177 sources its claims cite is checked for support yet.

Abstract

Gene transcription by RNA Polymerase II (Pol II) is highly vulnerable to transcription-blocking DNA lesions (TBLs), which, if unresolved, induce transcription stress leading to cellular decline and aging. TBLs are removed by transcription-coupled nucleotide excision repair (TC-NER). TC-NER is initiated when Cockayne syndrome group B protein recognizes lesion-stalled Pol II and promotes TC-NER complex assembly. This complex recruits TFIIH for lesion verification, followed by incision and repair to enable transcription restart. Many TBLs stall Pol II within its active site, shielding the lesion from repair and requiring Pol II processing to expose it. However, whether this occurs through Pol II backtracking or release from the DNA, and the regulatory mechanisms involved, remain poorly defined. Here, we identified the Integrator complex as a key factor in lesion-stalled Pol II processing. Interaction proteomics revealed Integrator recruitment to late-stage TC-NER complexes. Integrator’s endonuclease core promotes efficient transcription recovery after TBL induction, without affecting lesion removal by TC-NER. Live-cell imaging and chromatin retention assays demonstrated that Integrator facilitates Pol II release from DNA following TC-NER. Collectively, these findings support a two-step mechanism for Pol II clearance during TC-NER, wherein TFIIH-mediated backtracking exposes the lesion for repair, followed by Integrator-mediated Pol II release to restore transcription.

Overview

CoChat Summary

TL;DR

The Integrator complex is recruited to late-stage TC-NER complexes, and its endonuclease core promotes transcription recovery after transcription-blocking lesions without affecting TC-NER-mediated repair. It acts after TFIIH-dependent lesion exposure to release previously lesion-stalled Pol II from chromatin, supporting a two-step Pol II clearance model.

Key findings

  • Interaction proteomics identified Integrator as a top factor with reduced binding to transcriptionally engaged Pol II in STK19 KO cells after UV; 13 of 15 quantified Integrator subunits were reduced similarly to UVSSA and TFIIH. INTS11 immunoprecipitation from chromatin showed UV-induced interaction with CSB, CSA, XPB, and XPD, which was lost upon NAEi or spironolactone treatment.
  • INTS11 depletion severely impaired transcription recovery after UV (8 J/m²) and Illudin S, comparable to CSB depletion; INTS9 depletion gave similar results, and catalytic-inactive INTS11 E203Q failed to rescue whereas WT INTS11 did. Recovery after flavopiridol washout was unaffected.
  • INTS11 was dispensable for TC-NER repair: CSB FRAP remobilization, Pol II ubiquitylation, TFIIH recruitment to elongating Pol II, trabectedin-induced ssDNA breaks, and TCR-UDS were all normal in INTS11-depleted cells.
  • INTS11 depletion increased the UV-induced immobile Pol II fraction by ∼50% and left pSer2 Pol II largely unchanged, whereas WT cells showed a ∼50% decrease; DRB run-off showed delayed release of lesion-stalled Pol II at local UV damage. No such effect was seen in UVSSA KO, spironolactone-treated, or formaldehyde/DPC conditions, while XPA KO cells still depended on INTS11.

Methods

  • Cell lines and perturbations: HCT116, RPE1, and HeLa cells, including Halo-HA-INTS11 KI, GFP-RPB1 KI, CSB-mScarletI KI, and TC-NER KO lines; treatments included UV-C, Illudin S, trabectedin, formaldehyde, flavopiridol, PROTAC3, siRNA/shRNA, and inhibitors.
  • Proteomics and biochemical assays: SILAC-based interaction proteomics of pSer2-modified Pol II in WT versus STK19 KO cells after UV, chromatin fractionation, immunoprecipitation, and immunoblotting.
  • Functional assays: EU incorporation for nascent transcription/recovery, FRAP live-cell imaging, flow cytometry, immunofluorescence, alkaline comet assay, TCR-UDS, and local DRB run-off; statistics used unpaired two-tailed t-tests.

Limitations

  • Stated: Integrator depletion only partially affects Pol II removal, suggesting additional parallel clearance mechanisms such as XRN2, TTF2, PCF11, and RPRD1B; the authors cannot exclude that Integrator recognizes a stalled, non-productive TC-NER intermediate independent of productive Pol II backtracking; local transcription restart at the repair site cannot be ruled out.
  • Stated: residual INTS11 after PROTAC3-mediated depletion may explain the less severe transcription recovery defect after Illudin S compared with CSB KO cells.
  • Evident from the text: the TFIIH-mediated backtracking step is inferred from dependency on TFIIH/STK19 and from the absence of an INTS11 effect in DPC/UVSSA KO conditions, rather than directly visualized; many conclusions rely on depletion/rescue and imaging assays.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/nar/gkag1068

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Image 1
CC BY · From the PDF
Figure 1 Integrator complex binds to lesion-stalled Pol II dependent on STK19. ( A ) Reanalysis of SILAC-based quantitative interaction proteomics of the UV-induced pSer2-modified RPB1 subunit of Pol II. Log2 SILAC ratios of HCT116 WT versus STK19 knockout (KO) cells upon UV irradiation (16 J/m 2 , 1 h), including a SILAC label-swap replicate, were plotted. Pol II subunits are depicted in black. TC-NER proteins are indicated in red, subunits of the TFIIH complex in green, and subunits of the Integrator complex in orange. ( B ) Log2 SILAC ratios of pSer2-modified Pol II interactors in WT versus STK19 KO cells upon UV-damage as shown in panel (A). ( C ) Top 5 enriched GO terms (cellular component) identified using g:Profiler of STK19-dependent proteins that bind to elongating Pol II upon UV-induced damage as shown in Fig. 1 A, with a Log2 SILAC ratio > 0.6. ( D ) IP in the solubilized chromatin fraction of Halo-HA-INTS11 using HA beads in Halo-HA-INTS11 KI cells followed by immunoblotting for the indicated proteins. Where indicated, cells were pretreated with NAEi (10 μ M, 30 min) or spironolactone (10 μ M, 2 h) before harvesting. Cells were collected 1 h after mock treatment or after irradiation with 16 J/m 2 UV. BC: binding control.
Figure 1 Integrator complex binds to lesion-stalled Pol II dependent on STK19. ( A ) Reanalysis of SILAC-based quantitative interaction proteomics of the UV-induced pSer2-modified RPB1 subunit of Pol II. Log2 SILAC ratios of HCT116 WT versus STK19 knockout (KO) cells upon UV irradiation (16 J/m 2 , 1 h), including a SILAC label-swap replicate, were plotted. Pol II subunits are depicted in black. TC-NER proteins are indicated in red, subunits of the TFIIH complex in green, and subunits of the Integrator complex in orange. ( B ) Log2 SILAC ratios of pSer2-modified Pol II interactors in WT versus STK19 KO cells upon UV-damage as shown in panel (A). ( C ) Top 5 enriched GO terms (cellular component) identified using g:Profiler of STK19-dependent proteins that bind to elongating Pol II upon UV-induced damage as shown in Fig. 1 A, with a Log2 SILAC ratio > 0.6. ( D ) IP in the solubilized chromatin fraction of Halo-HA-INTS11 using HA beads in Halo-HA-INTS11 KI cells followed by immunoblotting for the indicated proteins. Where indicated, cells were pretreated with NAEi (10 μ M, 30 min) or spironolactone (10 μ M, 2 h) before harvesting. Cells were collected 1 h after mock treatment or after irradiation with 16 J/m 2 UV. BC: binding control.CC BY · From the PDF
Image 3
CC BY · From the PDF
Figure 2 Integrator complex facilitates transcription recovery after transcription-blocking damage. ( A ) Immunoblot analysis (left) and quantification (right) of INTS11, INTS9, and HA from lysates of HCT116 Halo-HA-INTS11 KI cells treated with PROTAC3 (0.3 μ M) for the indicated timepoints. Protein levels
Figure 2 Integrator complex facilitates transcription recovery after transcription-blocking damage. ( A ) Immunoblot analysis (left) and quantification (right) of INTS11, INTS9, and HA from lysates of HCT116 Halo-HA-INTS11 KI cells treated with PROTAC3 (0.3 μ M) for the indicated timepoints. Protein levelsCC BY · From the PDF
Image 5
CC BY · From the PDF
Image 6
CC BY · From the PDF
Figure 3 INTS11 is not essential for TC-NER. ( A ) (Left) FRAP analysis of CSB in HCT116 CSB-mScarletI Halo-HA-INTS11 KI cells upon UV irradiation (4 J/m 2 ). Cells were pretreated with PROTAC3 (0.6 μ M, 24 h) as indicated. CSB-mScarletI was bleached in a strip across the nucleus and fluorescence intensity was measured every 0.4 s for 11.6 s in untreated cells or at the different timepoints after UV irradiation (4 J/m 2 ). n = 36 cells per condition from at least three independent experiments. CSB-mScarletI RFI was background-corrected and normalized to pre-bleach fluorescence intensity and set to 1. (Right) Calculated immobile fraction of CSB-mScarletI after DNA damage obtained from the data points in the dotted box indicated in left (timepoints 10.0 s-11.6 s). Immobile fraction in WT and INTS11-depleted cells was calculated by comparing RFI after UV to mock-treated sample and normalizing to their own non-irradiated RFI values. n = 36 cells per condition from three independent experiments ± SEM. Statistical significance was determined using an unpaired t wo-t ailed Student's t -test (ns, non-significant). ( B ) Immunoblot using the indicated antibodies of the chromatin fraction of HCT116 Halo-HA-INTS11 or CSB-Halo KI cells 1 h after 12 J/m 2 UV or mock treatment. Where specified, cells were pre-treated with PROTAC3 (0.3 μ M, 16 h) to deplete INTS11 or CSB. Tubulin was used as a loading control. ( C ) IP in the solubilized chromatin fraction of pSer2 Pol II in mockand UV-treated (16 J/m 2 , 1 h) HCT116 CSB-mScarletI and Halo-HA-INTS11 KI cells and CSB-Halo KI cells, followed by immunoblot with the indicated antibodies. Where indicated, cells were pre-treated with PROTAC3 (0.6 μ M, 24 h) to deplete INTS11. Right, chromatin-fraction input samples. BC, binding control agarose beads. ( D ) Alkaline comet assays of HCT116 Halo-HA-INTS11 KI cells and HCT116 CSB-Halo KI cells upon pre-treatment with PROTAC3 (0.6 μ M, 24 h) as indicated, either untreated or exposed to trabectedin (30 nM) for 2 h in the presence of HU (1 mM) and AraC (10 μ M). The percentage of DNA present in the comet tail (%) per cell was plotted. Black lines indicate average integrated density of the DNA in the tail ± SEM from n = 6 for Halo-HA-INTS11 KI cells and n = 3 for CSB-Halo KI cells ( n ≥ 169 cells per condition). Statistical significance was determined using an unpaired t wo-t ailed Student's t ( ∗∗ P < . 01, ∗∗∗∗ P < . 0 0 01). ( E ) TCR-UDS as determined by EdU incorporation upon UV exposure (8 J/m 2 ) in RPE1 XPC KO Halo-HA-INTS11 KI cells. Where specified, cells were pre-treated with PROTAC3 (0.3 μ M, 24 h) and/or with 2 μ M THZ1. Mean RFI of fluorescent labeled EdU was normalized to ' + UV -PROTAC3' levels and set to 100%. Black lines indicate average integrated density ± SEM from three independent experiments ( n ≥ 302 cells per condition). Statistical significance was determined using an unpaired two-tailed Student's t -test (ns, non-significant).
Figure 3 INTS11 is not essential for TC-NER. ( A ) (Left) FRAP analysis of CSB in HCT116 CSB-mScarletI Halo-HA-INTS11 KI cells upon UV irradiation (4 J/m 2 ). Cells were pretreated with PROTAC3 (0.6 μ M, 24 h) as indicated. CSB-mScarletI was bleached in a strip across the nucleus and fluorescence intensity was measured every 0.4 s for 11.6 s in untreated cells or at the different timepoints after UV irradiation (4 J/m 2 ). n = 36 cells per condition from at least three independent experiments. CSB-mScarletI RFI was background-corrected and normalized to pre-bleach fluorescence intensity and set to 1. (Right) Calculated immobile fraction of CSB-mScarletI after DNA damage obtained from the data points in the dotted box indicated in left (timepoints 10.0 s-11.6 s). Immobile fraction in WT and INTS11-depleted cells was calculated by comparing RFI after UV to mock-treated sample and normalizing to their own non-irradiated RFI values. n = 36 cells per condition from three independent experiments ± SEM. Statistical significance was determined using an unpaired t wo-t ailed Student's t -test (ns, non-significant). ( B ) Immunoblot using the indicated antibodies of the chromatin fraction of HCT116 Halo-HA-INTS11 or CSB-Halo KI cells 1 h after 12 J/m 2 UV or mock treatment. Where specified, cells were pre-treated with PROTAC3 (0.3 μ M, 16 h) to deplete INTS11 or CSB. Tubulin was used as a loading control. ( C ) IP in the solubilized chromatin fraction of pSer2 Pol II in mockand UV-treated (16 J/m 2 , 1 h) HCT116 CSB-mScarletI and Halo-HA-INTS11 KI cells and CSB-Halo KI cells, followed by immunoblot with the indicated antibodies. Where indicated, cells were pre-treated with PROTAC3 (0.6 μ M, 24 h) to deplete INTS11. Right, chromatin-fraction input samples. BC, binding control agarose beads. ( D ) Alkaline comet assays of HCT116 Halo-HA-INTS11 KI cells and HCT116 CSB-Halo KI cells upon pre-treatment with PROTAC3 (0.6 μ M, 24 h) as indicated, either untreated or exposed to trabectedin (30 nM) for 2 h in the presence of HU (1 mM) and AraC (10 μ M). The percentage of DNA present in the comet tail (%) per cell was plotted. Black lines indicate average integrated density of the DNA in the tail ± SEM from n = 6 for Halo-HA-INTS11 KI cells and n = 3 for CSB-Halo KI cells ( n ≥ 169 cells per condition). Statistical significance was determined using an unpaired t wo-t ailed Student's t ( ∗∗ P < . 01, ∗∗∗∗ P < . 0 0 01). ( E ) TCR-UDS as determined by EdU incorporation upon UV exposure (8 J/m 2 ) in RPE1 XPC KO Halo-HA-INTS11 KI cells. Where specified, cells were pre-treated with PROTAC3 (0.3 μ M, 24 h) and/or with 2 μ M THZ1. Mean RFI of fluorescent labeled EdU was normalized to ' + UV -PROTAC3' levels and set to 100%. Black lines indicate average integrated density ± SEM from three independent experiments ( n ≥ 302 cells per condition). Statistical significance was determined using an unpaired two-tailed Student's t -test (ns, non-significant).CC BY · From the PDF
Image 8
CC BY · From the PDF
Figure 4 INTS11 results in prolonged chromatin-binding of Pol II after DNA damage. ( A ) Pol II levels in HCT116 GFP-RPB1 Halo-HA-INTS11 KI cells were quantified by flow cytometry. Where indicated, cells were pre-treated with PROTAC3 (0.3 μ M, 16 h) and/or NAEi (10 μ M, 30 min) to block CRL4 CSA activity. Cells were mock-treated or irradiated with UV (12 J/m 2 ) and analyzed at the indicated timepoints. GFP-RPB1 levels in UV-irradiated cells were normalized to undamaged controls for each cell line (set at 100). Columns represent the mean RFI of at least four independent experiments of > 10 0 0 0 cells ± SEM. Statistical significance was assessed by an unpaired t wo-t ailed Student's t -test (ns, non-significant). ( B ) (Left) Representative IF images of pSer2-modified Pol II, GFP-RBP1, and INTS11 levels in GFP-RPB1 Halo-HA-INTS11 KI cells either non treated (NT) or 8 h after UV exposure (8 J/m 2 ). Cycloheximide (100 μ M) was added 2 h prior to UV-irradiation and maintained for the duration of the experiment. Where indicated, cells were pre-treated with PROTAC3 (0.3 μ M, 16 h). Scale bar, 25 μ m. (Right) Quantification of elongating pSer2-modified Pol II(top chart) and total Poll II levels (bottom chart) as determined by GFP-RPB1 levels as determined by IF . The RFI was normalized to mock-treated levels and set at 100. Black lines indicate average RFI intensity and error bars ± SEM. n ≥ 418 cells per condition from three independent experiments. Statistical significance was determined using an unpaired t wo-t ailed Student's t -test ( ∗∗∗∗ P < . 0 0 01). ( C ) (Left) FRAP analysis of Pol II mobility in mockand UV-treated (4 J/m 2 , 1 h) RPE1 GFP-RPB1 Halo-HA-INTS11 KI cells. PROTAC3 (0.3 μ M, 24 h) pre-treatment was done when indicated. GFP-RPB1 RFI was background-corrected and normalized to pre-bleach fluorescence intensity and set to 1. n ≥ 31 cells per condition from at least four independent experiments. (Right) Calculated immobile fraction of GFP-RPB1 after DNA damage obtained from the data points in the dotted box indicated in left (timepoints 199.4 s-239.4 s). Immobile fraction in WT and INTS11-depleted cells was calculated by comparing RFI after UV to mock-treated sample and normalizing to their own non-irradiated RFI values. n ≥ 31 cells per condition from at least four independent experiments ± SEM. Statistical significance was determined using an unpaired t wo-t ailed Student's t -test ( ∗∗ P < . 01).
Figure 4 INTS11 results in prolonged chromatin-binding of Pol II after DNA damage. ( A ) Pol II levels in HCT116 GFP-RPB1 Halo-HA-INTS11 KI cells were quantified by flow cytometry. Where indicated, cells were pre-treated with PROTAC3 (0.3 μ M, 16 h) and/or NAEi (10 μ M, 30 min) to block CRL4 CSA activity. Cells were mock-treated or irradiated with UV (12 J/m 2 ) and analyzed at the indicated timepoints. GFP-RPB1 levels in UV-irradiated cells were normalized to undamaged controls for each cell line (set at 100). Columns represent the mean RFI of at least four independent experiments of > 10 0 0 0 cells ± SEM. Statistical significance was assessed by an unpaired t wo-t ailed Student's t -test (ns, non-significant). ( B ) (Left) Representative IF images of pSer2-modified Pol II, GFP-RBP1, and INTS11 levels in GFP-RPB1 Halo-HA-INTS11 KI cells either non treated (NT) or 8 h after UV exposure (8 J/m 2 ). Cycloheximide (100 μ M) was added 2 h prior to UV-irradiation and maintained for the duration of the experiment. Where indicated, cells were pre-treated with PROTAC3 (0.3 μ M, 16 h). Scale bar, 25 μ m. (Right) Quantification of elongating pSer2-modified Pol II(top chart) and total Poll II levels (bottom chart) as determined by GFP-RPB1 levels as determined by IF . The RFI was normalized to mock-treated levels and set at 100. Black lines indicate average RFI intensity and error bars ± SEM. n ≥ 418 cells per condition from three independent experiments. Statistical significance was determined using an unpaired t wo-t ailed Student's t -test ( ∗∗∗∗ P < . 0 0 01). ( C ) (Left) FRAP analysis of Pol II mobility in mockand UV-treated (4 J/m 2 , 1 h) RPE1 GFP-RPB1 Halo-HA-INTS11 KI cells. PROTAC3 (0.3 μ M, 24 h) pre-treatment was done when indicated. GFP-RPB1 RFI was background-corrected and normalized to pre-bleach fluorescence intensity and set to 1. n ≥ 31 cells per condition from at least four independent experiments. (Right) Calculated immobile fraction of GFP-RPB1 after DNA damage obtained from the data points in the dotted box indicated in left (timepoints 199.4 s-239.4 s). Immobile fraction in WT and INTS11-depleted cells was calculated by comparing RFI after UV to mock-treated sample and normalizing to their own non-irradiated RFI values. n ≥ 31 cells per condition from at least four independent experiments ± SEM. Statistical significance was determined using an unpaired t wo-t ailed Student's t -test ( ∗∗ P < . 01).CC BY · From the PDF
Figure 5 Integrator complex stimulates chromatin release of lesion-stalled Pol II. ( A ) Schematic cartoon of the Pol II DRB run-off assay to compare the release of lesion-stalled Pol II at sites of local damage, with that of non-damage stalled Pol II outside of the local damage. Cells were irradiated with UV
Figure 5 Integrator complex stimulates chromatin release of lesion-stalled Pol II. ( A ) Schematic cartoon of the Pol II DRB run-off assay to compare the release of lesion-stalled Pol II at sites of local damage, with that of non-damage stalled Pol II outside of the local damage. Cells were irradiated with UVCC BY · From the PDF
Figure 6 Integrator complex stimulates a two-step mechanism of Pol II processing at TBLs. Model showing the Integrator complex function during the cellular response to transcription-blocking DNA damage. ( A ) Transcription-blocking lesions block Pol II-meditated transcription, by blocking the Pol II forward movement in the active site of Pol II. As a consequence Pol II shields the damage. After detection of lesion-stalled Pol II the TC-NER complex is assembled. ( B ) The Integrator complex is recruited during a late stage of the TC-NER reaction, downstream of STK19 recruitment at the reaction step in which TFIIH is recruited and correctly positioned for damage proofreading. ( C ) For correct handover of the lesion from the TC-NER initiating complex to the TC-NER incision complex, Pol II needs to be removed from the lesion, while remaining bound to the DNA. The likely scenario is that Pol II is backtracked by the 5 ′ -3 ′ translocase activity of the TFIIH subunit XPD. ( D ) Pol II backtracking allows TBL removal by the incision complex and subsequent gap filling of the ssDNA gap. ( E ) In parallel, the catalytic core of the Integrator complex stimulates chromatin release of the backtracked Pol II, which would otherwise formed persistent roadblocks for newly initiated elongation complexes. ( F ) By removing the initially lesion-stalled Pol II, INTS11 facilitates proper transcription recovery by de novo transcription initiation from the transcription start site (TSS). Fig. 6 ( https:// biorender.com/ pae7et5 ) was created using BioRender.
Figure 6 Integrator complex stimulates a two-step mechanism of Pol II processing at TBLs. Model showing the Integrator complex function during the cellular response to transcription-blocking DNA damage. ( A ) Transcription-blocking lesions block Pol II-meditated transcription, by blocking the Pol II forward movement in the active site of Pol II. As a consequence Pol II shields the damage. After detection of lesion-stalled Pol II the TC-NER complex is assembled. ( B ) The Integrator complex is recruited during a late stage of the TC-NER reaction, downstream of STK19 recruitment at the reaction step in which TFIIH is recruited and correctly positioned for damage proofreading. ( C ) For correct handover of the lesion from the TC-NER initiating complex to the TC-NER incision complex, Pol II needs to be removed from the lesion, while remaining bound to the DNA. The likely scenario is that Pol II is backtracked by the 5 ′ -3 ′ translocase activity of the TFIIH subunit XPD. ( D ) Pol II backtracking allows TBL removal by the incision complex and subsequent gap filling of the ssDNA gap. ( E ) In parallel, the catalytic core of the Integrator complex stimulates chromatin release of the backtracked Pol II, which would otherwise formed persistent roadblocks for newly initiated elongation complexes. ( F ) By removing the initially lesion-stalled Pol II, INTS11 facilitates proper transcription recovery by de novo transcription initiation from the transcription start site (TSS). Fig. 6 ( https:// biorender.com/ pae7et5 ) was created using BioRender.CC BY · From the PDF

Verification

Claims the paper makes

0 Valid · 0 Not valid · 79 Not checked · 154 Own results and interpretations

131 more claims

Create a free account to see all 233 claims and to verify the 177 references still open.

See all claims — free account
  • It may state two separate claims as one. 65
  • Probably not a substantial claim. 45

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 113 references

Cited by

Still being checked.

Metadata

Authors
Blom, C. M. A., Gómez-Vázquez, E., van Sluis, M., & Marteijn, J. A.
Affiliations
  • Erasmus MC (NL)
  • Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center , 3015 GD,Rotterdam ,
Corresponding author
Marteijn, Jurgen A
Venue
Nucleic Acids Research
Published
2026-10-24
Volume
54
Issue
20
Pages
gkag1068
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W7224996954
Cited by
0
References
113
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by)
Funders
  • Dutch Cancer Society (14817)
  • Netherlands Organization for Scientific Research
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
Keywords
Integrator complex, RNA polymerase II, transcription-coupled repair, TFIIH, aging
MeSH terms
Excision Repair, DNA Damage, DNA Repair, DNA-Binding Proteins, Humans, RNA Polymerase II, Transcription Factors, Transcription, Genetic, Transcription Factor TFIIH

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart. https://app.cochat.ai/papers/10.1093/nar/gkag1068
The paper
Blom, C. M. A., Gómez-Vázquez, E., van Sluis, M., & Marteijn, J. A. (2026). Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag1068

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.